Literature DB >> 315267

Disseminated histiocytosis X: analysis of prognostic factors based on a retrospective study of 50 cases.

C Nezelof, F Frileux-Herbet, J Cronier-Sachot.   

Abstract

This work is a retrospective study of 50 cases of DHX, collected over a period of 27 years. 24 children died, 26 are still alive. The prognosis for DHX was neither dependent on age (usually occurring in children under 2 years) nor on histological findings but on the extent of the lesions. It was possible to establish a clinical staging system distinguishing 2 groups. One, where the disease was severe and almost always fatal, often included the combined symptoms of thrombocytopenia, spontaneous anemia, jaundice, hepatosplenomegaly, respiratory insufficiency and absence of osteolytic lesions. The other, with a favorable prognosis, was characterized by skin lesions, diabetes insipidus, exclusively radiological pulmonary involvement and multiple bone lesions. In cases where death did not occur, DHX was often chronic, frequently persisting for 2 years or more and leading to serious sequelae such as diabetes insipidus, growth stunting, intellectual retardation, blindness or deafness.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 315267     DOI: 10.1002/1097-0142(197911)44:5<1824::aid-cncr2820440542>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  23 in total

1.  Endocrine aspects of Langerhans cell histiocytosis.

Authors:  A T Soliman; I Alsalmi; N E Banna; M Asfour
Journal:  Indian J Pediatr       Date:  1996 May-Jun       Impact factor: 1.967

2.  Bone marrow findings at diagnosis in patients with multisystem langerhans cell histiocytosis.

Authors:  Maria Laura Galluzzo; Jorge Braier; Sergio D Rosenzweig; Maria T Garcia de Dávila; Diego Rosso
Journal:  Pediatr Dev Pathol       Date:  2010 Mar-Apr

3.  Chronic dermal sinuses as a manifestation of histiocytosis X.

Authors:  S H Sacks; I Hall; N Ragge; J Pritchard
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-26

4.  Histiocytosis X: response to chemotherapy.

Authors:  S J Whittaker; R R Jones
Journal:  J R Soc Med       Date:  1988-06       Impact factor: 5.344

5.  Case report 508: Histiocytosis X of the left femur-proximal segment.

Authors:  C P Adler; H E Schaefer
Journal:  Skeletal Radiol       Date:  1988       Impact factor: 2.199

6.  Suppressor-cell dysfunction in children with histiocytosis-X.

Authors:  B T Shannon; W A Newton
Journal:  J Clin Immunol       Date:  1986-11       Impact factor: 8.317

7.  Thyroid localization in adult histiocytosis X.

Authors:  A A Sinisi; T Criscuolo; L Palombini; A Bellastella; M Faggiano
Journal:  J Endocrinol Invest       Date:  1986-10       Impact factor: 4.256

8.  A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. The French Langerhans' Cell Histiocytosis Study Group.

Authors: 
Journal:  Arch Dis Child       Date:  1996-07       Impact factor: 3.791

9.  Eosinophilic granuloma of the temporal bone.

Authors:  P Quesada; M L Navarrete; E Perelló
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

10.  Pulmonary histiocytosis X in adult patients.

Authors:  D Huhn; G König; J Weig; W Schneller
Journal:  Klin Wochenschr       Date:  1981-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.